Healthcare provider profile · identity verified

Leslie Joan Rigali, DO

Internal Medicine · PEABODY, MA · NPI 1609860857

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	526	162
Levothyroxine Sodium	Levothyroxine Sodium	429	122
Amlodipine Besylate	Amlodipine Besylate	411	121
Lisinopril	Lisinopril	408	126
Gabapentin	Gabapentin	368	76
Omeprazole	Omeprazole	365	123
Metoprolol Succinate	Metoprolol Succinate	303	95
Losartan Potassium	Losartan Potassium	270	84
Simvastatin	Simvastatin	270	84
Lorazepam	Lorazepam	224	53
Trazodone Hcl	Trazodone Hcl	223	58
Tramadol Hcl	Tramadol Hcl	205	46
Hydrochlorothiazide	Hydrochlorothiazide	199	65
Furosemide	Furosemide	190	50
Atenolol	Atenolol	160	53
Pantoprazole Sodium	Pantoprazole Sodium	144	43
Sertraline Hcl	Sertraline Hcl	144	44
Rosuvastatin Calcium	Rosuvastatin Calcium	143	42
Oxycodone Hcl	Oxycodone Hcl	141	28
Duloxetine Hcl	Duloxetine Hcl	126	33
Pregabalin	Pregabalin	119	18
Diclofenac Sodium	Diclofenac Sodium	118	39
Fluticasone Propionate	Fluticasone Propionate	115	39
Fluoxetine Hcl	Fluoxetine Hcl	112	28
Alprazolam	Alprazolam	109	24
Metformin Hcl Er	Metformin Hcl	108	35
Warfarin Sodium	Warfarin Sodium	107	21
Allopurinol	Allopurinol	105	28
Albuterol Sulfate Hfa	Albuterol Sulfate	104	46
Metformin Hcl	Metformin Hcl	99	33
Ozempic	Semaglutide	99	16
Citalopram Hbr	Citalopram Hydrobromide	96	27
Pravastatin Sodium	Pravastatin Sodium	96	31
Tamsulosin Hcl	Tamsulosin Hcl	91	28
Eliquis	Apixaban	89	25
Escitalopram Oxalate	Escitalopram Oxalate	85	25
Zolpidem Tartrate	Zolpidem Tartrate	83	17
Celecoxib	Celecoxib	80	15
Clonazepam	Clonazepam	79	13
Famotidine	Famotidine	77	23
Bupropion Xl	Bupropion Hcl	68	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	64	24
Potassium Chloride	Potassium Chloride	63	15
Lovastatin	Lovastatin	58	14
Ventolin Hfa	Albuterol Sulfate	58	17
Levetiracetam	Levetiracetam	57	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	56	suppressed
Spironolactone	Spironolactone	56	14
Trulicity	Dulaglutide	56	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	53	13
Alendronate Sodium	Alendronate Sodium	51	18
Metoprolol Tartrate	Metoprolol Tartrate	48	18
Valacyclovir	Valacyclovir Hcl	48	16
Prednisone	Prednisone	44	31
Clopidogrel	Clopidogrel Bisulfate	43	14
Mirtazapine	Mirtazapine	43	16
Ibuprofen	Ibuprofen	41	15
Ropinirole Hcl	Ropinirole Hcl	40	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	38	suppressed
Synthroid	Levothyroxine Sodium	37	11
Glipizide Er	Glipizide	36	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	35	11
Buspirone Hcl	Buspirone Hcl	35	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	11
Valsartan	Valsartan	35	suppressed
Clonidine Hcl	Clonidine Hcl	33	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	33	suppressed
Montelukast Sodium	Montelukast Sodium	33	13
Topiramate	Topiramate	33	suppressed
Donepezil Hcl	Donepezil Hcl	32	13
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	30	suppressed
Ezetimibe	Ezetimibe	29	suppressed
Nystatin	Nystatin	29	17
Wixela Inhub	Fluticasone Propion/Salmeterol	28	suppressed
Methocarbamol	Methocarbamol	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Arnuity Ellipta	Fluticasone Furoate	25	suppressed
Estradiol	Estradiol	25	13
Hydroxyzine Hcl	Hydroxyzine Hcl	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	24	14
Finasteride	Finasteride	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	15
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	22	13
Glimepiride	Glimepiride	22	suppressed
Hydrocortisone	Hydrocortisone	22	suppressed
Midodrine Hcl	Midodrine Hcl	22	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	22	suppressed
Baclofen	Baclofen	21	suppressed
Cephalexin	Cephalexin	21	20
Jardiance	Empagliflozin	21	suppressed
Ondansetron Odt	Ondansetron	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	16
Chlorthalidone	Chlorthalidone	20	suppressed
Linzess	Linaclotide	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Irbesartan	Irbesartan	18	suppressed
Klor-Con M20	Potassium Chloride	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Carvedilol	Carvedilol	17	suppressed
Fluconazole	Fluconazole	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Meloxicam	Meloxicam	15	suppressed
Metronidazole	Metronidazole	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Glipizide	Glipizide	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Zubsolv	Buprenorphine Hcl/Naloxone Hcl	13	suppressed
Azithromycin	Azithromycin	12	12
Diazepam	Diazepam	12	suppressed
Galantamine Hbr	Galantamine Hbr	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error